These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5750222)

  • 21. Synthesis and enzymic activity of some novel xanthine oxidase inhibitors. 3-Substituted 5,7-dihydroxypyrazolo(1,5-alpha)pyrimidines.
    Springer RH; Dimmitt MK; Novinson T; O'Brien DE; Robins RK; Simon LN; Miller JP
    J Med Chem; 1976 Feb; 19(2):291-6. PubMed ID: 2778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The existence of nonfunctional active sites in milk xanthine oxidase: reaction with functional active site inhibitors.
    Massey V; Komai H; Palmer G; Elion GB
    Vitam Horm; 1970; 28():505-31. PubMed ID: 4335890
    [No Abstract]   [Full Text] [Related]  

  • 23. The inhibition of reduction of tetrazolium by a protein liver.
    Fried R; Fried LW; Babin D
    Eur J Biochem; 1970 Nov; 16(3):399-406. PubMed ID: 5477285
    [No Abstract]   [Full Text] [Related]  

  • 24. The composition of milk xanthine oxidase.
    Hart LI; McGartoll MA; Chapman HR; Bray RC
    Biochem J; 1970 Mar; 116(5):851-64. PubMed ID: 5441374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and properties of immobilised xanthine oxidase.
    Coughlan MP; Johnson DB
    Biochim Biophys Acta; 1973 Apr; 302(2):200-4. PubMed ID: 4739733
    [No Abstract]   [Full Text] [Related]  

  • 26. Behavior of N-methylated allopurinols and related 4-thioxopyrazolo [3,4-d]pyrimidines towards bovine milk xanthine oxidase.
    Bergmann F; Frank A; Govrin H
    Biochim Biophys Acta; 1979 Sep; 570(1):215-20. PubMed ID: 486504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the mechanism of inactivation of xanthine oxidase by allopurinol and other pyrazolo[3,4-d]pyrimidines.
    Massey V; Komai H; Palmer G; Elion GB
    J Biol Chem; 1970 Jun; 245(11):2837-44. PubMed ID: 5467924
    [No Abstract]   [Full Text] [Related]  

  • 28. [Properties of milk xanthine oxidase and its isoenzymes with different contents of molybdenum and copper in the feed].
    Koval'skiĭ VV; Vorotinitskaia IE; Tsoĭ GG
    Dokl Akad Nauk SSSR; 1973 Jul; 211(2):481-4. PubMed ID: 4730569
    [No Abstract]   [Full Text] [Related]  

  • 29. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS.
    HALL AP; HOLLOWAY VP; SCOTT JT
    Ann Rheum Dis; 1964 Nov; 23(6):439-46. PubMed ID: 14229577
    [No Abstract]   [Full Text] [Related]  

  • 30. One-electron transfer reactions in biochemical systems. VII. Two types of electron outlets in milk xanthine oxidase.
    Nakamura M; Yamazaki I
    Biochim Biophys Acta; 1973 Dec; 327(2):247-56. PubMed ID: 4360425
    [No Abstract]   [Full Text] [Related]  

  • 31. N-Hydroxyguanidine compound 1-(3,4-dimethoxy- 2-chlorobenzylideneamino)-3-hydroxyguanidine inhibits the xanthine oxidase mediated generation of superoxide radical.
    Dambrova M; Baumane L; Kiuru A; Kalvinsh I; Wikberg JE
    Arch Biochem Biophys; 2000 May; 377(1):101-8. PubMed ID: 10775447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bovine intestinal xanthine oxidase: a metalloflavoprotein containing iron, copper, and flavin adenine dinucleotide.
    Roussos GG; Morrow BH
    Arch Biochem Biophys; 1966 Jun; 114(3):599-601. PubMed ID: 5957717
    [No Abstract]   [Full Text] [Related]  

  • 33. Improved xanthine oxidase purification.
    Hart LI; Bray RC
    Biochim Biophys Acta; 1967; 146(2):611-3. PubMed ID: 4965225
    [No Abstract]   [Full Text] [Related]  

  • 34. The isolation of demolybdo xanthine oxidase from bovine milk.
    Ventom AM; Deistung J; Bray RC
    Biochem J; 1988 Nov; 255(3):949-56. PubMed ID: 2850803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bovine milk xanthine oxidase fractions of improved potency; isolation of molybdenum-free, iron-poor, active preparations.
    Roussos GG; Morrow BH
    Biochem Biophys Res Commun; 1967 Nov; 29(3):388-93. PubMed ID: 5624541
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of antiuric action of 4-oxy- and 4-thiopyrazolopyrimidines.
    Cartier PH; Hamet M
    Biochem Pharmacol; 1973 Dec; 22(23):3061-75. PubMed ID: 4761565
    [No Abstract]   [Full Text] [Related]  

  • 37. The resolution of active and inactive xanthine oxidase by affinity chromatography.
    Edmondson D; Massey V; Palmer G; Beacham LM; Elion GB
    J Biol Chem; 1972 Mar; 247(5):1597-604. PubMed ID: 4335003
    [No Abstract]   [Full Text] [Related]  

  • 38. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion.
    Enroth C; Eger BT; Okamoto K; Nishino T; Nishino T; Pai EF
    Proc Natl Acad Sci U S A; 2000 Sep; 97(20):10723-8. PubMed ID: 11005854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of bovine milk xanthine oxidase as a dehydrogenase form.
    Nakamura M; Yamazaki I
    J Biochem; 1982 Oct; 92(4):1279-86. PubMed ID: 6959993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase.
    Chalmers RA; Parker R; Simmonds HA; Snedden W; Watts RW
    Biochem J; 1969 May; 112(4):527-32. PubMed ID: 5801674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.